Back

Investor Relations  Financial Information

Segment and Regional Information

Consolidated Financial Results by Business Segment

Net Sales

(Unit: Millions of yen)
 Medical-RelatedPharmaceutical-RelatedPharmaPackagingOtherTotal
'14/3 221,362 51,507 27,610 271 300,752
'15/3 237,777 57,372 29,830 104 325,084
'16/3 272,167 62,266 32,184 32 366,650
'17/3 262,198 69,140 28,331 29 359,699

* Reporting Segment was changed as a result of the corporate reorganization. The segment information is presented as if the reorganization had been conducted at the beginning of the fiscal year 2014.

Operating Income

(Unit: Millions of yen)
 Medical-RelatedPharmaceutical-RelatedPharmaPackagingOtherAdjustmentTotal
'14/3 20,435 8,013 -2,182 216 -14,192 12,289
'15/3 23,812 10,553 -2,889 131 -15,036 16,571
'16/3 28,203 12,059 -1,618 61 -14,502 24,204
'17/3 30,638 14,135 -1,313 -10 -14,679 28,770

Net Sales by Region

(Unit: Millions of yen)
 JapanAmericaEuropeAsiaTotal
Net salesProportion Net salesProportion Net salesProportion Net salesProportion Net sales
'14/3 174,860 58.1% 56,887 19.0% 40,434 13.4% 28,570 9.5% 300,752
'15/3 182,148 56.0% 62,661 19.3% 42,874 13.2% 37,399 11.5% 325,084
'16/3 203,461 55.5% 72,416 19.7% 46,156 12.6% 44,615 12.2% 366,650
'17/3 221,331 61.5% 53,239 14.8% 42,579 11.9% 42,548 11.8% 359,699

Proportion of Net Sales by Region (2017/3)

Page top